• You need to sign in or sign up before continuing.
Close
0
0
29 words
0
Comments
The FDA underscored cases including two deaths and a suicide linked to patients taking semaglutide
You are the first to view
https://www.wsj.com/health/pharma/fda-warns-novo-nordisk-of-unreported-side-effects-tied-to-glp-1-patients-c97d810e
Create an account or login to join the discussion